Hubei Jinjian Biology Co., Ltd. is registered in Xianning City, Hubei Province. There is a 12-person professional R&D team, including 2 doctors, 3 masters, and 7 undergraduates. Both of them have more than 15 years of experience in IVD reagent research and development, production and quality management. At present, it has obtained 3 invention patent acceptance documents and 10 utility model patents from the State  Intellectual Property Office, and has undertaken 2 development projects above the provincial level. The novel coronavirus (2019- nCoV) IgM/IgG antibody detection kit and the new coronavirus (SARS-CoV-2) antigen detection kit have obtained CE certification, and the China Chamber of Commerce for Import and Export of Medicines and Health Products has whitelisted (export qualification). British Lloyd's ISO13485 authoritative certification, and passed the Chinese customs inspection and quarantine, and is applying for product registration in Japan, Singapore, and Malaysia, which can meet the needs of foreign countries for the detection of the new coronavirus epidemics. 

Based on strong RD team in Wuhan Optical Valley, 1,200㎡ of 100k level clean workshops, adopting leading technology platform such as fluorescence quantitative chromatography (POCT), magnetic particle tube chemiluminescence and colloidal gold, we released kinds of rapid test kits to detect inflammation, myocardial infarction, gastropathy , kidney disease etc.. In order to aid in identifying individuals with an adaptive immune response to SARS-CoV-2, IgM/IgG antibody test kit developed. For identification of SARS-CoV-2 nucleocapsid antigen purpose, 2019-nCoV antigen test kits are available.

On February 9, 2021, our company(Hubei Jinjian Biology Co.,Ltd) successfully obtained the CE certification for our Novel Coronavirus Neutralizing Antibody Test Kit(Colloidal Gold Method), it can provide an easy way for the preliminary screening of NAb to estimate humanbody’ immunity to novel coronavirus infection.